The cardiac arrhythmia suppression trial (CAST).
暂无分享,去创建一个
[1] D. Echt,et al. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation. , 1989, Circulation.
[2] Cardiac Arrhythmia Pilot Study Investigators. Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS. , 1988, The American journal of cardiology.
[3] J. Anderson,et al. Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide. , 1986, Journal of the American College of Cardiology.
[4] E. Prystowsky,et al. Drug conversion of nonsustained ventricular tachycardia to sustained ventricular tachycardia during serial electrophysiologic studies: identification of drugs that exacerbate tachycardia and potential mechanisms. , 1982, American heart journal.
[5] W. Rogers,et al. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. , 1989, The New England journal of medicine.
[6] R. Winkle,et al. Malignant ventricular tachyarrhythmias associated with the use of encainide. , 1981, American heart journal.
[7] E. Prystowsky,et al. Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapy. , 1988, The New England journal of medicine.